{
  "ticker": "JNJ",
  "target_date": "2025-09-16",
  "actual_date": "2025-09-16",
  "collected_at": "2025-12-08T12:17:09.806031",
  "price": {
    "open": 176.45,
    "high": 176.5,
    "low": 174.54,
    "close": 175.34669494628906,
    "volume": 7959300,
    "change_1d_pct": -0.53,
    "change_7d_pct": -1.1,
    "change_30d_pct": 3.93
  },
  "technicals": {
    "rsi_14": 49.88,
    "sma_20": 176.24,
    "sma_50": 169.32,
    "macd": 1.904,
    "macd_signal": 2.536,
    "macd_histogram": -0.632,
    "bb_upper": 178.06,
    "bb_lower": 174.42,
    "price_vs_sma20_pct": -0.51,
    "price_vs_sma50_pct": 3.56,
    "volume_ratio": 1.05
  },
  "fundamentals": {
    "market_cap": 487532888064,
    "pe_ratio": 19.532335,
    "forward_pe": 19.090094,
    "price_to_book": 6.141834,
    "price_to_sales": 5.290702,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.62,
    "pct_from_52w_low": 43.84
  },
  "macro": {
    "spy": {
      "price": 658.18,
      "change_1d_pct": -0.14,
      "change_7d_pct": 1.72
    },
    "vix": {
      "level": 16.36,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.03
    },
    "dollar_index": {
      "level": 96.63
    },
    "gold": {
      "price": 3688.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Guggenheim Reiterates a Hold on Johnson & Johnson (JNJ)",
      "source": "Yahoo",
      "datetime": 1758052688,
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best drug stocks to buy right now. On September 10, Guggenheim analyst Vamil Divan reiterated a Hold rating on Johnson & Johnson (NYSE:JNJ) and set a price target of $167.00. The rating update followed Johnson & Johnson\u2019s (NYSE:JNJ) announcement on Septembe",
      "url": "https://finnhub.io/api/news?id=c6728e007507f4c53363a0e92ce50c43077d9450f67b02fc46752dc0ffe8d04d"
    },
    {
      "headline": "Wolfe Research Lifts PT for Johnson & Johnson (JNJ), Keeps Outperform Rating",
      "source": "Yahoo",
      "datetime": 1758052245,
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 Unrivaled Stocks of the Next 3 Years. On September 3, Wolfe Research increased the price target for Johnson & Johnson (NYSE:JNJ) from $175 to $195 and kept an Outperform rating. Wolfe Research cited growing confidence in Johnson & Johnson\u2019s (NYSE:JNJ) up",
      "url": "https://finnhub.io/api/news?id=0420bf01d20da5f448ded22a23ae1da3d6521b05ae6f7f1a4aa22422bcedd862"
    },
    {
      "headline": "GSK Says It Will Spend $30B on U.S. Manufacturing and R&D",
      "source": "MarketWatch",
      "datetime": 1758049260,
      "summary": "GSK Says It Will Spend $30B on U.S. Manufacturing and R&D",
      "url": "https://finnhub.io/api/news?id=a9cc0127fb52e5bad111cbe0fae4993c98de24e14a4e6477842edd38fbb9d840"
    },
    {
      "headline": "Johnson & Johnson (JNJ)\u2019s Dividend Legacy: How a Healthcare Giant Built a Record of Consistent Dividends",
      "source": "Yahoo",
      "datetime": 1758035372,
      "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 13 Best Consistent Dividend Stocks to Buy Now. Johnson & Johnson (NYSE:JNJ) is an American multinational pharmaceutical, biotech, and medical technologies company. It has a highly diversified business with a wide range of medicines in its pharmaceut",
      "url": "https://finnhub.io/api/news?id=93d147d08eed4ddc798eb7747ace335ffdfb74cf5ffdfc685e21a197785d817d"
    },
    {
      "headline": "Top 20 Companies Recognized in Labrador Transparency\u2019s 2025 U.S. Transparency Awards",
      "source": "Yahoo",
      "datetime": 1758029340,
      "summary": "ATLANTA, September 16, 2025--Lowe\u2019s Companies, Dow, American Express, ConocoPhillips, and AIG secured top honors in the 2025 U.S. Transparency Awards announced today by Labrador Transparency, a leading global communications firm specializing in transparent corporate disclosure documents. The ranking",
      "url": "https://finnhub.io/api/news?id=75420e9be9f7e8461d4b1bd23b0c1d423e6d18e68108fe32d20c23c76dac3867"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}